Anti-inflammatory activity of the Tongmai Yangxin Pill in the treatment of Coronary Heart Disease is associated with Estrogen Receptor and NF-κB signaling pathway

Publication date: Available online 7 April 2021Source: Journal of EthnopharmacologyAuthor(s): Yadong Fan, Jianwei Liu, Jing Miao, Xiaoyu Zhang, Yiqi Yan, Liding Bai, Jun Chang, Ying Wang, Li Wang, Yuhong Bian, Huifang Zhou
Source: Journal of Ethnopharmacology - Category: Drugs & Pharmacology Source Type: research